ASX · NC6.AX
Nanollose Limited
A$0.07-A$0.00 (-3.9%)
Nanollose Limited’s quoted price sits in the upper half of its reported 52-week range, 10.84% below the high.
Loading market information…
ASX · AGH.AX · AUD
Stock price, earnings
Quote as of Dec 5, 2025, 02:54 AM UTC. Cached market data; not a live quote.
One-year closing-price history · AUD. Historical prices are not a forecast.
Althea Group Holdings Limited’s quoted price sits in the lower half of its reported 52-week range, 44.44% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Althea Group Holdings Limited’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Althea Group Holdings Limited is engaged in the cultivation, distribution, and sale of both therapeutic and recreational cannabis products across a global footprint, including Australia, the United Kingdom, Germany, and Canada. Beyond its product offerings, the company provides essential support services, such as educational programs, access facilitation, and treatment management, to empower eligible patients and healthcare professionals in navigating the landscape of medicinal cannabis. Althea also actively formulates and manufactures a diverse array of recreational cannabis items, ranging from beverages and edibles to concentrates and topicals. Furthermore, it owns and operates the MyAccess Clinics, a network of private medical cannabis clinics. The company was founded in Melbourne, Australia, in 2016.
Latest available per-share figures in AUD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 06:11 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
A$0.07-A$0.00 (-3.9%)
Nanollose Limited’s quoted price sits in the upper half of its reported 52-week range, 10.84% below the high.
A$0.02A$0.00 (0.0%)
Neurotech International Limited’s quoted price sits in the upper half of its reported 52-week range, 19.05% below the high.
A$0.04-A$0.00 (-2.22%)
IDT Australia Limited’s quoted price sits in the lower half of its reported 52-week range, 29.03% below the high.
A$0.35+A$0.02 (+4.55%)
ImExHS Limited’s quoted price sits in the lower half of its reported 52-week range, 26.6% below the high.
A$0.05A$0.00 (0.0%)
BTC Health Limited’s quoted price sits in the lower half of its reported 52-week range, 27.14% below the high.
A$0.02A$0.00 (0.0%)
MedAdvisor Limited’s quoted price sits in the lower half of its reported 52-week range, 93.02% below the high.
A$0.03-A$0.00 (-3.57%)
Firebrick Pharma Limited’s quoted price sits in the lower half of its reported 52-week range, 63.51% below the high.
A$0.02-A$0.00 (-4.0%)
Patrys Limited’s quoted price sits in the lower half of its reported 52-week range, 53.85% below the high.
